PROGNOSTIC VALUE OF MOLECULAR GENETIC MARKERS IN KIDNEY CANCER PATIENTS RECEIVING TARGETED THERAPY

PROGNOSTIC VALUE OF MOLECULAR GENETIC MARKERS IN KIDNEY CANCER PATIENTS RECEIVING TARGETED THERAPY

Show other versions (1)

<p><strong>Objective: </strong>to study the prognostic value of alterations in the VHL gene and the plasma markers hVEGF, hVEGFR2, and hVEGFR3 in patients with metastatic kidney cancer (KC) who receive targeted therapy.</p><p><strong>Subjects and methods. </str...

Full description

Bibliographic Details
Main Authors: M. V. Peters, V. E. Shevchenko, V. B. Matveev, M. I. Volkova, S. A. Kalinin, D. M. Mikhailenko, D. V. Zaletayev
Format: Article
Language:Russian
Published: ABV-press 2014-07-01
Series:Onkourologiâ
Subjects:
targeted therapy
VHL gene alterations
plasma markers
prognostic value
Online Access:http://oncourology.abvpress.ru/index.php/oncur/article/view/185

Internet

http://oncourology.abvpress.ru/index.php/oncur/article/view/185

Similar Items